Main Problems and Development Trends in Nuclear Forensics
Russian Journal of Legal Studies (Moscow) · 2022
DOI: 10.17816/rjls106562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Journal of Legal Studies (Moscow), 2022. Verfasst von Alina I. Nitrean und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
An analysis of the materials and reports on international forums organized by the International Atomic Energy Agency resulted in the compilation of a description of incidents involving illicit trafficking in nuclear and other radioactive materials (NRM). Mistakes made during the incident investigations were revealed, which include the lack of interaction between NRM specialists, forensic experts, and law enforcement agencies during the investigation of criminal cases, collection, examination of evidence, and formulation of insufficiently justified conclusions. The informativeness of the analytical methods is shown, the most informative of them are identified; further, the directions for the development of the methodological support of the forensic examination of nuclear weapons are determined. Additionally, the approaches of training in the field of nuclear forensics and the possibilities of involving the resources of international organizations in this activity are identified.
Zitieren
APA
Nitrean, A. I., & Stebelkov, V. A. (2022). Main Problems and Development Trends in Nuclear Forensics. Russian Journal of Legal Studies (Moscow). https://doi.org/10.17816/rjls106562
Vancouver
Nitrean AI, Stebelkov VA. Main Problems and Development Trends in Nuclear Forensics. Russian Journal of Legal Studies (Moscow). 2022. doi:10.17816/rjls106562
BibTeX
@article{Nitrean2022,
author = {Nitrean, Alina I. and Stebelkov, Vladimir A.},
title = {Main Problems and Development Trends in Nuclear Forensics},
journal = {Russian Journal of Legal Studies (Moscow)},
year = {2022},
doi = {10.17816/rjls106562}
}
EUVIMED